Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

2015 in science and Solanezumab

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between 2015 in science and Solanezumab

2015 in science vs. Solanezumab

A number of significant scientific events occurred in 2015. Solanezumab (proposed INN, LY2062430) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector for patients with Alzheimer's disease.

Similarities between 2015 in science and Solanezumab

2015 in science and Solanezumab have 2 things in common (in Unionpedia): Alzheimer's disease, Amino acid.

Alzheimer's disease

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time.

2015 in science and Alzheimer's disease · Alzheimer's disease and Solanezumab · See more »

Amino acid

Amino acids are organic compounds containing amine (-NH2) and carboxyl (-COOH) functional groups, along with a side chain (R group) specific to each amino acid.

2015 in science and Amino acid · Amino acid and Solanezumab · See more »

The list above answers the following questions

2015 in science and Solanezumab Comparison

2015 in science has 728 relations, while Solanezumab has 26. As they have in common 2, the Jaccard index is 0.27% = 2 / (728 + 26).

References

This article shows the relationship between 2015 in science and Solanezumab. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »